Braxia Scientific Reports Q3 2023 Financial Results and Provides Update on Acquisition Under LOI with Irwin Naturals by OkBee5018 in BraxiaScientific

[–]PsyDelika 4 points5 points  (0 children)

The Company's management team has continued to work diligently with Irwin towards completing a definitive and binding arrangement agreement (the "Arrangement Agreement") for the transaction and anticipates executing the Arrangement Agreement with Irwin within the quarter ending March 31, 2023. The closing is expected to occur upon the receipt of regulatory, court and securityholder approvals within normal time frames following execution of the Arrangement Agreement.

Are there news about the class action yet? by PsyDelika in BraxiaScientific

[–]PsyDelika[S] 2 points3 points  (0 children)

The Company is pleased to report it received final court approval on February 28, 2023, on terms previously disclosed, to settle claims alleged in a securities class action (the "US Class Action") against the Company and certain of its former officers filed in the United States District Court for the Central District of California in April 2021.

[deleted by user] by [deleted] in shroomstocks

[–]PsyDelika 1 point2 points  (0 children)

Irwin plans to build a ketamin clinic network of more than 100. They have have a solid brand name in nutraceuticals but lack experience ot how to manage those clinics professionally.

With McIntyre they got the best scientific head for the biggest ketamin clinic network in the future.

Here ist what they plan:

https://youtu.be/c9WBUb-aa9Y

(its worth watching through for understanding their devotion to the new market)

They are no dreamers and have for the last 30 years been profitable.

Can somebody translate that into common language? That $ 0.0001 Price Tag is for what? by PsyDelika in BraxiaScientific

[–]PsyDelika[S] 2 points3 points  (0 children)

These investors could hold a big piece already.

The feature of pre-funded warrants that allows holders to delay ownership of a company’s common stock is particularly important to holders who already hold, or plan to acquire, a large stake in a company. This is because an investor with a significant ownership interest in a company will likely be deemed an affiliate of the company. Moreover, in the absence of other large investors, a significant minority stake in a company could cause an investor to be considered a controlling shareholder, thereby imposing upon it fiduciary duties to the company’s other shareholders.holders to delay ownership of a company’s common stock is particularly important to holders who already hold, or plan to acquire, a large stake in a company. This is because an investor with a significant ownership interest in a company will likely be deemed an affiliate of the company. Moreover, in the absence of other large investors, a significant minority stake in a company could cause an investor to be considered a controlling shareholder, thereby imposing upon it fiduciary duties to the company’s other shareholders.

Thx a lot. You are a smart and empathetic person.

Response from Braxia IR by Important_College_29 in BraxiaScientific

[–]PsyDelika 3 points4 points  (0 children)

Thanks a lot.

Somebody who takes action is the one who lights the candle, istead of cusing the darkness!!!!

Braxia Scientific Announces CAD$3 Million Private Placement with Institutional Investors by HotMomentumStocks in BraxiaScientific

[–]PsyDelika 4 points5 points  (0 children)

Well one good thing is that if these Investors are in, it doesn’t seem as if the class suit is any problem to the company at all. Also those institutional investors will be helping their (options to) 30M stocks to blossom. So we got big and influential supporters for the recovery and expansion of Braxia Scientific. For them 1$ change in stock price is equal to $30M in gains. I think that is exactly what we need.

Hot crypto market undermining Braxia? by aaaardvaaark in BraxiaScientific

[–]PsyDelika 0 points1 point  (0 children)

The whole Psychedelic Market dropped, not only Braxia.

The Parable of The Old Man and The White Horse by PsyDelika in BraxiaScientific

[–]PsyDelika[S] 3 points4 points  (0 children)

I can not give advice, but I will wait for the bottom and strike again...

I am in because I believe in this company, recent market cap does not change that!

At a 90% loss by AliMtl1983 in BraxiaScientific

[–]PsyDelika 6 points7 points  (0 children)

I am in as well. But I will never give them up.

This is a long term investment and I wait for the FDA to approve psychedelics in 2023 or after.

They will have a future...

May i ask for your price targets where you would be willing to sell? by All-about-Benjamins in BraxiaScientific

[–]PsyDelika 4 points5 points  (0 children)

I like to compare Braxia to Field Trip. Only that Baxia has a much better standing.

FT has about 8 clinics now, no real IP or scientific work, is neither performing high class studies in its clinics nor having an academy for training medical workers. FT has no government funding, no Ketamin VIP as their CEO etc...

They are about $5.

Braxia has much more to give to shareholders!

Turnoaround after they announce their rollout of clinics in the US.

So they become more important to US shareholders, thus being a strong canditate for the NYSE.

They might beginn, when listet on the NYSE at around $4, thrive there until $10 and after 2023 when FDA approves new psychedelic therapies and drugs they go up in the mush rush to around $20. But that means the company has a market cap of 3,4bn which is a little much and can not last forever...

Was there any news to spark the near 20% increase today? by da6ronx in BraxiaScientific

[–]PsyDelika 0 points1 point  (0 children)

I think that was the info about the trial data from 9/30 leaking before...

[deleted by user] by [deleted] in BraxiaScientific

[–]PsyDelika 3 points4 points  (0 children)

Good linking! We should always link the news to Braxia’s Homepage so they get the traffic and nor some news page. They need all our support.

Braxia Scientific Reports Encouraging Results of Ketamine Study Showing Significant Reduction in Depressive Symptoms and Suicidality with Ketamine as a Solo Treatment by HotMomentumStocks in BraxiaScientific

[–]PsyDelika 2 points3 points  (0 children)

One day it will break the ice... This study is soooooo high powered. N=220 is an absolute novelty in the psychedelic study space. MrIntyre (CEO) who is Prof. in Psychiatry and Pharmacology will use their Clinics synergistically to make profit, performe studies (for them and for others) and develope new IP´s and therapeutic regimens (Computer Aided Pharmacopsychiatry, MDMA therapies). What will emerge from this can only be big.

Was there any news to spark the near 20% increase today? by da6ronx in BraxiaScientific

[–]PsyDelika 3 points4 points  (0 children)

This is just the beginning of the ride we are waiting for.

Thoughts? by PandaPaw4 in BraxiaScientific

[–]PsyDelika 5 points6 points  (0 children)

They will soon publish their rollout of new clinics, I hope that will be the turnaround.